Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP623019.RAAQUzvgwWa_BCW1KUiYxxvTkNq_8ioWj2qDdPLroix-I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP623019.RAAQUzvgwWa_BCW1KUiYxxvTkNq_8ioWj2qDdPLroix-I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP623019.RAAQUzvgwWa_BCW1KUiYxxvTkNq_8ioWj2qDdPLroix-I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP623019.RAAQUzvgwWa_BCW1KUiYxxvTkNq_8ioWj2qDdPLroix-I130_provenance.
- NP623019.RAAQUzvgwWa_BCW1KUiYxxvTkNq_8ioWj2qDdPLroix-I130_assertion description "[The mechanism of action of certain antidepressant drugs, particularly the tricyclics and the newly available norepinephrine and serotonin reuptake inhibitors (NSRIs) drugs, venlafaxine and nefazodone, suggest that the norepinephrine transporter, which is a target for these antidepressant drugs, and its malfunction may be involved in major depression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623019.RAAQUzvgwWa_BCW1KUiYxxvTkNq_8ioWj2qDdPLroix-I130_provenance.
- NP623019.RAAQUzvgwWa_BCW1KUiYxxvTkNq_8ioWj2qDdPLroix-I130_assertion evidence source_evidence_literature NP623019.RAAQUzvgwWa_BCW1KUiYxxvTkNq_8ioWj2qDdPLroix-I130_provenance.
- NP623019.RAAQUzvgwWa_BCW1KUiYxxvTkNq_8ioWj2qDdPLroix-I130_assertion SIO_000772 10512149 NP623019.RAAQUzvgwWa_BCW1KUiYxxvTkNq_8ioWj2qDdPLroix-I130_provenance.
- NP623019.RAAQUzvgwWa_BCW1KUiYxxvTkNq_8ioWj2qDdPLroix-I130_assertion wasDerivedFrom befree-20140225 NP623019.RAAQUzvgwWa_BCW1KUiYxxvTkNq_8ioWj2qDdPLroix-I130_provenance.
- NP623019.RAAQUzvgwWa_BCW1KUiYxxvTkNq_8ioWj2qDdPLroix-I130_assertion wasGeneratedBy ECO_0000203 NP623019.RAAQUzvgwWa_BCW1KUiYxxvTkNq_8ioWj2qDdPLroix-I130_provenance.
- befree-20140225 importedOn "2014-02-25" NP623019.RAAQUzvgwWa_BCW1KUiYxxvTkNq_8ioWj2qDdPLroix-I130_provenance.